Clinical Genetics · San Francisco, CA
NPI
1972034841
Since 2017
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
550 16th St # 706
San Francisco, CA, 94158
Phone (415) 476-5001
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$573K
54 prescriptions
Company payments, 2025
$1,484
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug David R Blair prescribed most often to Medicare patients was Fabrazyme (Agalsidase Beta), with 19 prescriptions and refills. In total David R Blair wrote 54 Medicare prescriptions that cost $573K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fabrazyme Agalsidase Beta | 19 | 19 | Under 11 | $130K |
| Vpriv Velaglucerase Alfa | 12 | 12 | Under 11 | $426K |
| Sodium Chloride 0.9 % Sodium Chloride | 11 | 11 | Under 11 | $6.18 |
Brand drugs: 54 claims; generic drugs: 0 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David R Blair $1,484 ($1,484 in general payments such as food, travel and fees) from 2 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $1,484.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 7 | $1,484 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.